Cummings James F. 4
4 · Vaxart, Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
Cummings James F.
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-03-18$0.57/sh−6,772$3,861→ 343,049 total - Tax Payment
Common Stock
2023-03-28$0.75/sh−3,267$2,451→ 349,821 total
Footnotes (4)
- [F1]This transaction is being reported late due to administrative oversight.
- [F2]Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2023.
- [F3]Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025.
- [F4]Includes 75,618 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.